About: Outcome of autologous stem cell transplantation for AL amyloidosis in the UK

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Outcome of autologous stem cell transplantation for AL amyloidosis in the UK Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 July 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2006 (uk) im August 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2006 (ast) scientific article published on 05 July 2006 (en)
publication date	wds:Q58853185-BF2599D0-327C-4364-B132-B47AFEBD8998
publication date	2006-07-05 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58853185-BA090CC9-08EA-48F4-B206-7E9AA3EB33A8
language of work or name	English
cites work	wds:Q58853185-0C35B1AA-CAC3-4568-A5F0-240C33A649F5 wds:Q58853185-12785888-F6B2-409B-AB59-E027AC2ECD93 wds:Q58853185-1FC9DE81-AA1E-490A-A722-4FB20F1F7B52 wds:Q58853185-4620E337-E278-44C2-B4E0-81E12D5C68E2 wds:Q58853185-489FDD16-2C69-4476-826E-3650377C7444 wds:Q58853185-4B8FF844-3A92-4007-A9AA-5A124E93519A wds:Q58853185-59A655AA-FB08-486A-82B4-0151154393CF wds:Q58853185-70A18D0C-A258-4D83-89BB-ED5817E3066D wds:Q58853185-7557DE9F-AB7D-48DF-8695-8921A4CED0B4 wds:Q58853185-94452D75-0772-4A30-9A50-86A9126723D7 wds:Q58853185-99F0790A-A3B6-473D-9CE1-FFFAF7407A16 wds:Q58853185-A1065860-9ED3-4E41-B126-B5BC50FAEC7A wds:Q58853185-A410E03B-8E55-43AE-AC86-12435FEA126E wds:Q58853185-B9B7BFB8-2054-4586-ABDB-6171B685B0FB wds:Q58853185-BBB1C163-C0E6-4B17-A518-BD46563C946F wds:Q58853185-C3E116C0-FC6F-463E-AF40-1D207AD154F6 wds:Q58853185-D532C6B8-8E39-4387-BE95-5B0C57BC2717 wds:Q58853185-E5A71F2E-B880-4F45-9D4C-812FC3FC2DB1 wds:Q58853185-EA8F408F-4CEC-43DF-A509-4DFD60447320 wds:Q58853185-FC7D39A7-8DC0-4B22-B788-54C73B41FB4E wds:Q58853185-FF21BF94-E3E1-4F68-BF5B-92CF03899E4A
cites work	High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Autologous stem cell transplantation for primary systemic amyloidosis Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Serum free light chains for monitoring multiple myeloma. Stem cell transplantation for the management of primary systemic amyloidosis High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study Guidelines on the diagnosis and management of AL amyloidosis Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study
author name string	wds:Q58853185-5C13E5A5-AA48-4CBB-8D70-16A913A00BB6 wds:Q58853185-C1863215-336F-4ED0-B491-DB7970CB65C0 wds:Q58853185-CB957610-44AF-417E-9504-BAABD1D8F466 wds:Q58853185-E7D8BDAC-E9F4-40A6-9351-8106D6E45672
author name string	Ashutosh D Wechalekar Julian D Gillmore Philip N Hawkins Hugh J B Goodman
rdfs:label	Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (en) Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (nl)
skos:prefLabel	Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (en) Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (nl)
name	Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (en) Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (nl)
author	wds:Q58853185-347918FC-7637-458C-8B78-CDB933D90015 wds:Q58853185-ECF1F1DF-65AA-485A-B891-54361CCD72FA
author	Helen J Lachmann Arthur R Bradwell
title	wds:Q58853185-D0E15662-AFDE-4859-8277-8EE23099F9E7
title	Outcome of autologous stem cell transplantation for AL amyloidosis in the UK (en)
page(s)	wds:Q58853185-5A5D97D1-03C1-400C-A80F-265905CBE5F5
page(s)	417-425
instance of	wds:Q58853185-A0208445-D697-4CDC-8636-6B3F993F9849
instance of	scholarly article
main subject	wds:Q58853185-07E0D38B-8899-451A-B6C4-BFB2C98645D5 wds:Q58853185-51BFDD9F-F715-4272-A0C1-5F491C907F45
main subject	AL amyloidosis stem cell transplantation
PubMed ID	wds:Q58853185-F4068D1E-9D47-44FA-B7D4-50BF7BF45779
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16822290
PubMed ID	16822290
published in	wds:Q58853185-9F4AF6A2-A3AC-4673-9D73-CDECB2357343
published in	British Journal of Haematology
issue	wds:Q58853185-F64E4B52-3C28-4209-ABC4-2B0810B34168
volume	wds:Q58853185-98AB5BD9-DFB4-4674-9077-8D8D9727A815
issue	4
volume	134
DOI	wds:Q58853185-F1A84729-B067-4EF6-974A-989D2D3B18CC
DOI	http://dx.doi.org/10.1111/J.1365-2141.2006.06204.X
DOI	10.1111/J.1365-2141.2006.06204.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58853185
is cites work of	Natural history and therapy of AL cardiac amyloidosis Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis Perspectives in treatment of AL amyloidosis Update on treatment of light chain amyloidosis Amyloidosis and POEMS syndrome

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software